Trial Profile

A randomized, double-blind, placebo-controlled, single and multiple ascending dose and food effect evaluation trial to evaluate the safety, tolerability, and pharmacokinetics of AQ280 in healthy subjects

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 30 Dec 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

17 May 2024 According to an Aqilion media release, results from this trial will be presented at The Annual Conference of International Drug Discovery and Science technology (IDDST) in Osaka, Japan on May 22-24 .
30 Oct 2023 Results presented in an Aqilion media release.
14 Aug 2023 According to an Aqilion media release, preliminary study results are expected in Q4 2023.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com